To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiv...
The China Medical University Hospital Clinical Trial Center (CMUH-CTC) is committed to enhancing clinical trials within ...
National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a coope...
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...
AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a n...
Japanese firm Sosei Group Corporation and US-based AbbVie, a research-based global biopharmaceutical company, have enter...
Rheumatoid arthritis (RA) treatment landscape in Australia is well established with several novel disease-modifying anti...
The hepatitis C virus (HCV) therapeutics market in Japan is highly competitive with stiff competition between Gilead and...
China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...
US-based AbbVie and Genmab announced on 10 June 2020 that they had formed the partnership that will focus on b...
